Isolation, identification and characterization of propionic acid bacteria associated with autistic spectrum disorder

Rongrong Yu1, Zhifeng Wu2, Shuhui Wang1

  • 1College of Education, Zhejiang University of Technology, Hangzhou, 310032, China.

Insights

Propionic acid (PA)-related bacteria are significantly less abundant in children with autism spectrum disorder (ASD). However, these bacteria show greater diversity in ASD children, suggesting a complex role in autism development.

Area of Science:

  • Microbiology
  • Neuroscience
  • Pediatric Health

Background:

  • Autism spectrum disorder (ASD) poses significant health challenges for children.
  • Propionic acid (PA) is increasingly implicated in the etiology of ASD.
  • Understanding the gut microbiome's role in ASD is crucial for developing targeted interventions.

Purpose of the Study:

  • To investigate the community structure of propionic acid (PA)-related bacteria in healthy versus ASD children.
  • To characterize representative PA-related bacterial strains and their sensitivity to PA.
  • To elucidate the impact of PA on bacterial growth, pH, and biofilm formation.

Main Methods:

  • Isolation and culturing of PA-related bacteria from healthy and ASD children.
  • Identification using colony morphology, biochemical tests, and 16S rRNA gene sequencing.
  • Assessment of bacterial sensitivity to PA, including pH changes and biofilm formation analysis.

Main Results:

  • PA-related bacteria were over 100-fold less abundant in ASD children compared to healthy children.
  • Greater diversity of PA-associated bacteria was observed in ASD children.
  • PA inhibited bacterial propagation rather than causing cell death, with varying sensitivity among species and conditions.

Conclusions:

  • The study reveals significant differences in PA-related bacterial communities between healthy and ASD children.
  • Findings highlight the potential role of PA-metabolizing bacteria in ASD pathogenesis.
  • Further research into these microbial communities may offer novel therapeutic targets for ASD.

Related Concept Videos